Meeting
2024 ASCO Annual Meeting
KRAS mutations allelic frequency dynamics using plasma extracellular vesicles: Association with survival outcomes in localized pancreatic adenocarcinoma.
Authors
Asmita Chopra
Department of Surgery, University of Pittsburgh, Pittsburgh, PA
Asmita Chopra , Hongzhang He , Jadranka Milosevic , Nikhil Tirukkovalur , Rudy El Asmar , Ibrahim Nassour , Geoffrey Nunns , Mingxi Chen , Jiaqi Chen , Siyu Jiang , Aatur D. Singhi , Anwaar Saeed , Janie Yue Zhang , Kenneth K. Lee , Amer H. Zureikat , Si-Yang Jiang , Alessandro Paniccia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer - Local-Regional Disease
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 4167)
DOI
10.1200/JCO.2024.42.16_suppl.4167
Abstract #
4167
Poster Bd #
147
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
New cutoff of CA19-9 values for predicting pancreatic cancer using liquid biopsy.
First Author: Ryuji Hasebe
Poster
2018 Gastrointestinal Cancers Symposium
Markov decision analysis of neoadjuvant treatment pathway versus surgery first pathway for resectable pancreatic cancer.
First Author: Alison Bradley
Poster
2012 Gastrointestinal Cancers Symposium
Association of KRAS G12D mutation with outcome in patients with pancreatic cancer after surgery.
First Author: Yo Mikayama
Poster
2024 ASCO Breakthrough
A potent and selective pan-RAS inhibitor, ADT-1004, targeting complex KRAS mutations for pancreatic cancer.
First Author: Gary Piazza